<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Treatment of tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Treatment of tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)</h1>
<div class="graphic"><div class="figure"><div class="ttl">Treatment of tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS)</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">TRAPS is an autoinflammatory disease with recurrent fevers and other symptoms. Secondary amyloidosis is a potential life-threatening complication. The goals of treatment are to control symptoms, prevent recurrent attacks, and reduce the risk of amyloidosis by suppressing inflammation.</div><div class="graphic_footnotes"><p>IL: interleukin; NSAID: nonsteroidal antiinflammatory drug; TNF: tumor necrosis factor; <em>TNFRSF1A</em>: TNF receptor superfamily member 1A.</p>
<p>* Features of a typical attack include one or more of the following: fever lasting ≥7 days, myalgia, migratory rash, periorbital edema, and abdominal pain.</p>
<p>¶ Typical length of treatment with an antiinflammatory dose of an NSAID such as naproxen or ibuprofen is 3 to 5 days.</p>
<p>Δ Some patients may need higher doses of prednisone or prednisolone (eg, 1 mg/kg twice daily) or may respond well to a lower initial dose (0.5 mg/kg/day).</p>
<p>◊ Frequent attacks are arbitrarily defined as more than 3 to 4 attacks per year.</p>
<p>§ Risk factors for amyloidosis include evidence of ongoing inflammation (frequent attacks, poor response of attacks to oral glucocorticoids, persistent elevation of inflammatory markers between attacks) and <em>TNFRSF1A</em> mutations classified as pathogenic or likely pathogenic.</p>
<p>¥ Starting dose of canakinumab is 2 mg/kg/dose (maximum dose 150 mg) subcutaneously once every <span class="nowrap_whitespace">4 weeks.</span> If the initial response is inadequate, the dose may be repeated after 7 days and subsequent maintenance doses may be increased to 4 mg/kg/dose (maximum dose 300 mg) every 4 weeks.</p>
<p>‡ Treatment failure is defined as inadequate symptom control (frequency and/or severity of attacks), persistent elevation of inflammatory markers, or evidence of amyloidosis.</p>
† Colchicine is useful for patients with pathogenic or likely pathogenic variants who exhibit an incomplete response to cytokine blockade with canakinumab, anakinra, or etanercept.</div><div id="graphicVersion">Graphic 142866 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
